title: Are the triptans for migraine therapy worth the cost?
abstract: The triptans represent a major advance in migraine therapy but their cost per dose greatly exceeds that of many older treatments. There is evidence that for a significant proportion of migraine patients these new drugs can show a positive cost benefit and also improve quality of life. Cost benefit would be expected to be greatest in patients with more severe migraine attacks.
authors.affiliation: Department of Clinical Neurosciences, Faculty of Medicine, University of Calgary, Alberta, Canada.
authors.forename: W J
authors.initials: WJ
authors.lastname: Becker
mesh_terms: D003362:Cost-Benefit Analysis; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D017366:Serotonin Receptor Agonists / Q000191:economics* / Q000627:therapeutic use*; D018170:Sumatriptan / Q000191:economics* / Q000627:therapeutic use*
chemical_list: D017366:Serotonin Receptor Agonists; D018170:Sumatriptan